Table 2. Association of GLB1 with Clinicopathologic Characteristics in Primary PCa Samples.
| Variable | Nucleus | Cytoplasm | ||
|---|---|---|---|---|
| Mean Intensity (SD) | p-value | Mean Intensity (SD) | p-value | |
| Gleason Score | ||||
| 6–7 | 1.84 (1.48) | 0.74 (0.73) | ||
| 8–9 | 1.73 (1.28) | 0.771 | 0.61 (0.48) | 0.418 |
| Stage | ||||
| II | 1.94 (1.45) | 0.75 (0.74) | ||
| III | 2.11 (1.47) | 0.7407 | 0.81 (0.52) | 0.7335 |
| IV | 0.97 (0.82) | 0.0075 | 0.37 (0.36) | 0.0249 |
| Presence of Metastases | ||||
| No | 1.98 (1.44) | 0.76 (0.69) | ||
| Yes | 0.97 (0.82) | 0.0036 | 0.37 (0.36) | 0.0108 |
| Age | ||||
| 45–54 | 2.28 (1.60) | 0.98 (0.92) | ||
| 55–64 | 1.43 (1.12) | 0.0795 | 0.48 (0.42) | 0.0637 |
| 65–74 | 2.05 (1.57) | 0.6961 | 0.77 (0.60) | 0.4789 |
| Extraprostatic Extension | ||||
| No | 1.85 (1.4) | 0.72 (0.69) | ||
| Yes | 1.66 (1.36) | 0.6504 | 0.63 (0.51) | 0.5897 |
| SV Involvement | ||||
| No | 1.94 (1.35) | 0.72 (0.66) | ||
| Yes | 1.26 (1.51) | 0.2293 | 0.56 (0.63) | 0.512 |
| PSA | ||||
| ≤5 | 2.26 (2.35) | 1.09 (1.27) | ||
| 5<x<10 | 1.83 (1.37) | 0.7746 | 0.65 (0.53) | 0.5954 |
| ≥10 | 1.6 (0.7) | 0.6683 | 0.61 (0.31) | 0.5639 |
| Tumor Volume(cc) | ||||
| <0.1 | 2.15 (1.65) | 0.86 (0.81) | ||
| 0.1≤x<0.3 | 1.71 (1.19) | 0.3846 | 0.63 (0.58) | 0.3395 |
| ≥0.3 | 1.63 (1.34) | 0.3504 | 0.59 (0.53) | 0.3017 |